Cellular FXIII in Human Macrophage-Derived Foam Cells
Open Access
- 2 March 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4802
Abstract
Macrophages express the A subunit of coagulation factor XIII (FXIII-A), a transglutaminase which cross-links proteins through Nε-(γ-L-glutamyl)-L-lysyl iso-peptide bonds. Macrophages are major cellular constituents of the atherosclerotic plaque; they may stabilize the plaque by cross-linking structural proteins and they may become transformed into foam cells by accumulating oxidized LDL (oxLDL). The combination of oxLDL staining by Oil Red O and immunofluorescent staining for FXIII-A demonstrated that FXIII-A is retained during the transformation of cultured human macrophages into foam cells. ELISA and Western blotting techniques revealed that the transformation of macrophages into foam cells elevated the intracellular FXIII-A content. This phenomenon seems specific for macrophage-derived foam cells; the transformation of vascular smooth muscle cells into foam cells fails to induce a similar effect. FXIII-A containing macrophages are abundant in the atherosclerotic plaque and FXIII-A is also present in the extracellular compartment. The protein cross-linking activity of FXIII-A in the plaque was demonstrated using an antibody labeling the iso-peptide bonds. Cells showing combined staining for FXIII-A and oxLDL in tissue sections demonstrated that FXIII-A-containing macrophages within the atherosclerotic plaque are also transformed into foam cells. Such cells may contribute to the formation of lipid core and the plaque structurization.Keywords
All Related Versions
Funding Information
- National Research, Development, and Innovation Office (NKFIH) (K129287, 11014, 11003, RS2015 006, PG/15/82/31721, FS/11/2/28579)
- European Union and the European Regional Development Fund (K129287, 11014, 11003, RS2015 006, PG/15/82/31721, FS/11/2/28579)
- Hungarian Academy of Science (K129287, 11014, 11003, RS2015 006, PG/15/82/31721, FS/11/2/28579)
- Eötvös Loránd Research Network (K129287, 11014, 11003, RS2015 006, PG/15/82/31721, FS/11/2/28579)
- University of Aberdeen Development TRUST (K129287, 11014, 11003, RS2015 006, PG/15/82/31721, FS/11/2/28579)
- British Heart Foundation (K129287, 11014, 11003, RS2015 006, PG/15/82/31721, FS/11/2/28579)
- British Heart Foundation Fellowship (K129287, 11014, 11003, RS2015 006, PG/15/82/31721, FS/11/2/28579)
This publication has 33 references indexed in Scilit:
- Oxidized LDL Induces Alternative Macrophage Phenotype through Activation of CD36 and PAFRMediators of Inflammation, 2013
- Smooth muscle cell phenotypic switching in atherosclerosisCardiovascular Research, 2012
- Factor XIII expression within aortic valves and its plasma activity in patients with aortic stenosis: association with severity of diseaseThrombosis and Haemostasis, 2012
- Factor XIII: A Coagulation Factor With Multiple Plasmatic and Cellular FunctionsPhysiological Reviews, 2011
- Factor XIII: novel structural and functional aspectsJournal of Thrombosis and Haemostasis, 2011
- Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophagesThrombosis and Haemostasis, 2010
- Possible role of factor XIII subunit A in Fcγ and complement receptor-mediated phagocytosisCellular Immunology, 2004
- Complement and AtherogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Identification of intracellular factor XIII in human monocytes and macrophages.Journal of Clinical Investigation, 1985
- Induction of tissue transglutaminase in human peripheral blood monocytes.Journal of Experimental Medicine, 1984